Adial Pharmaceuticals Stock Probability of Future Stock Price Finishing Under 0.01

ADIL Stock  USD 1.19  0.08  7.21%   
Adial Pharmaceuticals' future price is the expected price of Adial Pharmaceuticals instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Adial Pharmaceuticals performance during a given time horizon utilizing its historical volatility. Check out Adial Pharmaceuticals Backtesting, Adial Pharmaceuticals Valuation, Adial Pharmaceuticals Correlation, Adial Pharmaceuticals Hype Analysis, Adial Pharmaceuticals Volatility, Adial Pharmaceuticals History as well as Adial Pharmaceuticals Performance.
For more information on how to buy Adial Stock please use our How to buy in Adial Stock guide.
  
At this time, Adial Pharmaceuticals' Price Book Value Ratio is quite stable compared to the past year. Price To Book Ratio is expected to rise to 0.68 this year, although the value of Price Earnings To Growth Ratio will most likely fall to 0.01. Please specify Adial Pharmaceuticals' target price for which you would like Adial Pharmaceuticals odds to be computed.

Adial Pharmaceuticals Target Price Odds to finish below 0.01

The tendency of Adial Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to drop to $ 0.01  or more in 90 days
 1.19 90 days 0.01 
near 1
Based on a normal probability distribution, the odds of Adial Pharmaceuticals to drop to $ 0.01  or more in 90 days from now is near 1 (This Adial Pharmaceuticals probability density function shows the probability of Adial Stock to fall within a particular range of prices over 90 days) . Probability of Adial Pharmaceuticals price to stay between $ 0.01  and its current price of $1.19 at the end of the 90-day period is close to 99 .
Given the investment horizon of 90 days Adial Pharmaceuticals has a beta of -0.0489. This suggests as returns on the benchmark increase, returns on holding Adial Pharmaceuticals are expected to decrease at a much lower rate. During a bear market, however, Adial Pharmaceuticals is likely to outperform the market. Additionally Adial Pharmaceuticals has an alpha of 0.2548, implying that it can generate a 0.25 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Adial Pharmaceuticals Price Density   
       Price  

Predictive Modules for Adial Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Adial Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.051.094.95
Details
Intrinsic
Valuation
LowRealHigh
1.005.919.77
Details
Naive
Forecast
LowNextHigh
0.021.175.03
Details
3 Analysts
Consensus
LowTargetHigh
18.6620.5022.76
Details

Adial Pharmaceuticals Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Adial Pharmaceuticals is not an exception. The market had few large corrections towards the Adial Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Adial Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Adial Pharmaceuticals within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.25
β
Beta against Dow Jones-0.05
σ
Overall volatility
0.05
Ir
Information ratio 0.04

Adial Pharmaceuticals Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Adial Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Adial Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Adial Pharmaceuticals may become a speculative penny stock
Adial Pharmaceuticals had very high historical volatility over the last 90 days
Adial Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (7 M) with profit before overhead, payroll, taxes, and interest of 0.
Adial Pharmaceuticals currently holds about 9.16 M in cash with (6.81 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.35.
Adial Pharmaceuticals has a frail financial position based on the latest SEC disclosures
Latest headline from gurufocus.com: Adial Pharmaceuticals Granted Key U.S. Patent for the Treatment of Alcohol and Drug Dependence ...

Adial Pharmaceuticals Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Adial Stock often depends not only on the future outlook of the current and potential Adial Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Adial Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding1.4 M
Cash And Short Term Investments2.8 M

Adial Pharmaceuticals Technical Analysis

Adial Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Adial Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Adial Pharmaceuticals. In general, you should focus on analyzing Adial Stock price patterns and their correlations with different microeconomic environments and drivers.

Adial Pharmaceuticals Predictive Forecast Models

Adial Pharmaceuticals' time-series forecasting models is one of many Adial Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Adial Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Adial Pharmaceuticals

Checking the ongoing alerts about Adial Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Adial Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Adial Pharmaceuticals may become a speculative penny stock
Adial Pharmaceuticals had very high historical volatility over the last 90 days
Adial Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (7 M) with profit before overhead, payroll, taxes, and interest of 0.
Adial Pharmaceuticals currently holds about 9.16 M in cash with (6.81 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.35.
Adial Pharmaceuticals has a frail financial position based on the latest SEC disclosures
Latest headline from gurufocus.com: Adial Pharmaceuticals Granted Key U.S. Patent for the Treatment of Alcohol and Drug Dependence ...
When determining whether Adial Pharmaceuticals is a strong investment it is important to analyze Adial Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Adial Pharmaceuticals' future performance. For an informed investment choice regarding Adial Stock, refer to the following important reports:
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adial Pharmaceuticals. If investors know Adial will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adial Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.94)
Return On Assets
(1.04)
Return On Equity
(3.21)
The market value of Adial Pharmaceuticals is measured differently than its book value, which is the value of Adial that is recorded on the company's balance sheet. Investors also form their own opinion of Adial Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Adial Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adial Pharmaceuticals' market value can be influenced by many factors that don't directly affect Adial Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adial Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Adial Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adial Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.